NM_006270.5:c.631G>A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_006270.5(RRAS):​c.631G>A​(p.Gly211Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000772 in 1,438,128 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000075 ( 1 hom. )

Consequence

RRAS
NM_006270.5 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: -0.548

Publications

0 publications found
Variant links:
Genes affected
RRAS (HGNC:10447): (RAS related) The protein encoded by this gene is a small GTPase involved in diverse processes including angiogenesis, vascular homeostasis and regeneration, cell adhesion, and neuronal axon guidance. Mutations in this gene are found in many invasive cancers. [provided by RefSeq, Jul 2015]
RRAS Gene-Disease associations (from GenCC):
  • Noonan syndrome and Noonan-related syndrome
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • Noonan syndrome
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05129853).
BS2
High AC in GnomAd4 at 15 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RRASNM_006270.5 linkc.631G>A p.Gly211Arg missense_variant Exon 6 of 6 ENST00000246792.4 NP_006261.1 P10301A0A024QZF2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RRASENST00000246792.4 linkc.631G>A p.Gly211Arg missense_variant Exon 6 of 6 1 NM_006270.5 ENSP00000246792.2 P10301
RRASENST00000601532.1 linkn.*210G>A downstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0000990
AC:
15
AN:
151538
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000146
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000389
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000588
AC:
9
AN:
152940
AF XY:
0.0000370
show subpopulations
Gnomad AFR exome
AF:
0.000312
Gnomad AMR exome
AF:
0.0000611
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000890
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000386
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000746
AC:
96
AN:
1286590
Hom.:
1
Cov.:
31
AF XY:
0.0000812
AC XY:
51
AN XY:
627864
show subpopulations
African (AFR)
AF:
0.000325
AC:
9
AN:
27732
American (AMR)
AF:
0.0000401
AC:
1
AN:
24922
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18034
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33962
South Asian (SAS)
AF:
0.000101
AC:
6
AN:
59164
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47288
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4912
European-Non Finnish (NFE)
AF:
0.0000727
AC:
74
AN:
1018502
Other (OTH)
AF:
0.000115
AC:
6
AN:
52074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000990
AC:
15
AN:
151538
Hom.:
0
Cov.:
31
AF XY:
0.000135
AC XY:
10
AN XY:
73946
show subpopulations
African (AFR)
AF:
0.000146
AC:
6
AN:
41208
American (AMR)
AF:
0.00
AC:
0
AN:
15202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.000389
AC:
2
AN:
5142
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4790
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10530
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
308
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67912
Other (OTH)
AF:
0.00
AC:
0
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000132
Hom.:
0
Bravo
AF:
0.000117
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000582
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:2
Aug 06, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 10, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.631G>A (p.G211R) alteration is located in exon 6 (coding exon 6) of the RRAS gene. This alteration results from a G to A substitution at nucleotide position 631, causing the glycine (G) at amino acid position 211 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Noonan syndrome Uncertain:1
Dec 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 211 of the RRAS protein (p.Gly211Arg). This variant is present in population databases (rs369588682, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with RRAS-related conditions. ClinVar contains an entry for this variant (Variation ID: 582576). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
7.7
DANN
Benign
0.83
DEOGEN2
Benign
0.28
T
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.035
N
LIST_S2
Benign
0.35
T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.051
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.11
N
PhyloP100
-0.55
PrimateAI
Benign
0.44
T
PROVEAN
Benign
0.34
N
REVEL
Benign
0.054
Sift
Benign
0.17
T
Sift4G
Benign
0.18
T
Polyphen
0.0090
B
Vest4
0.14
MutPred
0.30
Gain of MoRF binding (P = 2e-04);
MVP
0.61
MPC
0.53
ClinPred
0.036
T
GERP RS
1.8
Varity_R
0.094
gMVP
0.38
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369588682; hg19: chr19-50138859; COSMIC: COSV55868502; COSMIC: COSV55868502; API